Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Do Analysts "Echo" Company Guidance?

For those wanting more evidence that analysts "echo" company guidance, here is more evidence from Health Care / Pharma stocks.

Earnings Guidance 2014

On 10-23-13 ABC projected 2014 adjusted EPS of $3.60 to $3.73, a 12%-16% increase over 2013.
Abbott is issuing ongoing earnings-per-share guidance for the full-year 2014 of $2.16 to $2.26.
On 1-26-14 AMGN projected 2014 revenues of $19.2-$19.6 billion and Adjusted EPS of $7.90-$8.20.
Baxter expects sales growth for 2014 of 9% to 10% and EPS of $5.05 to $5.25 per diluted share.
Becton projects 2014 diluted earnings per share from continuing operations to be between $6.16 and $6.22.
Bristol-Myers Squibb provides 2014 GAAP EPS guidance range of $1.75 to $1.90; Non-GAAP EPS guidance range of $1.65 to $1.80.
On 12-16-13 COV projected that 2014 that sales will be up 2% to 5% - and operating margin, excluding the impact of one-time items, to be in the 21.5% to 22.5% range.
Eli Lilly projects expects full-year 2014 earnings per share to be in the range of $2.77 to $2.85 on both a reported and non-GAAP basis.
On 1-24-14 JNJ projected 2014 adjusted EPS of $5.75 to $5.85.
On 5-07-13 MCK projected 2014 adjusted EPS of $7.90 and $8.20.
On 2-05-14 MRK projected 2014 Non-GAAP EPS of $3.35 to $3.53 - GAAP EPS of $2.15 to $2.47.
On 1-07-13 MDT projected 2013 EPS of $3.66 to $3.70. from the previously stated range of $3.62 to $3.70. The new range implies annual EPS growth of 6 to 7%. MDT started fiscal 2013 in May. In that earnings release of 5-22-12, MDT expected fiscal year 2013 diluted EPS in the range of $3.62 to $3.70.
On 8-15-13 PRGP projected 2014 GAAP EPS between $5.51 and $5.76 and adjusted EPS between $6.35 and $6.60.
On 1-22-14 Stryker projected 2014 EPS - excluding amortization of intangible assets - of $4.75 to $4.90.
TMO projects 2014 adjusted EPS in the range of $6.70 to $6.90, which would result in 24% to 27% adjusted EPS growth over 2013. The company expects to achieve 2014 revenue in the range of $16.63 billion to $16.83 billion, for 27% to 29% revenue growth year over year.
ZMH projected 2014 GAAP EPS in a range of $5.00 to $5.20 and $6.10 to $6.30 on an adjusted basis.

And below is the spreadsheet on P/E ratios where you can see the consensus EPS numbers - with the consensus numbers coming from Yahoo Finance:

Earnings Growth & P/E Ratios 06-20

Fiscal and calendar years are not in sync. MCK and MDT are already in fiscal 2015.


  Earnings / Share Earn. Growth P/E Ratios 14 EPS Range
Co. 2009 2010 2011 2012 2013 2014 2015 12-13 13-14 14-15 2013 2014 2015 High Low Range

ABBV 0 0 0 0 314 314 383 na 0.00% 21.97% 16.97 16.97 13.92 330 307 7.32%
ABC 167 219 251 276 314 372 428 13.77% 18.47% 15.05% 23.01 19.42 16.88 375 363 3.23%
ABT 0 0 0 174 201 220 248 15.52% 9.45% 12.73% 20.32 18.57 16.47 231 212 8.64%
AGN 0 0 0 414 477 570 685 15.22% 19.50% 20.18% 34.66 29.00 24.13 575 524 8.95%
AMGN 491 521 533 651 760 809 876 16.74% 6.45% 8.28% 15.92 14.95 13.81 864 776 10.88%
AZN 0 0 0 641 506 423 417 -21.06% -16.40% -1.42% 14.92 17.84 18.10 500 441 13.95%
BAX 380 398 431 453 467 514 544 3.09% 10.06% 5.84% 15.80 14.36 13.56 518 500 3.50%
BAYRY 0 0 0 688 745 804 917 8.28% 7.92% 14.05% 18.98 17.58 15.42 792 792 0.00%
BCR 509 560 640 657 578 821 913 -12.02% 42.04% 11.21% 24.28 17.09 15.37 828 720 13.15%
BDX 495 490 533 537 581 625 684 8.19% 7.57% 9.44% 20.39 18.95 17.32 652 618 5.44%
BMY 0 216 228 199 182 178 169 -8.54% -2.20% -5.06% 26.26 26.85 28.28 186 170 8.99%
COV 284 338 397 426 372 399 445 -12.68% 7.26% 11.53% 24.22 22.58 20.25 410 395 3.76%
GSK 0 0 0 353 373 349 403 5.67% -6.43% 15.47% 14.62 15.63 13.53 401 361 11.46%
JNJ 463 476 500 510 552 588 634 8.24% 6.52% 7.82% 19.07 17.90 16.60 602 579 3.91%
LLY 442 474 441 339 415 278 317 22.42% -33.01% 14.03% 14.95 22.31 19.57 288 275 4.68%
MCK 407 462 486 638 633 835 1066 -0.78% 31.91% 27.66% 29.30 22.21 17.40 885 811 8.86%

  Earnings / Share Earn. Growth P/E Ratios 14 EPS Range
Co. 2009 2010 2011 2012 2013 2014 2015 12-13 13-14 14-15 2013 2014 2015 High Low Range

MDT 292 322 337 346 375 382 405 8.38% 1.87% 6.02% 17.03 16.72 15.77 385 380 1.31%
MRK 325 342 377 382 349 347 364 -8.64% -0.57% 4.90% 16.88 16.98 16.19 375 307 19.60%
NVO 0 0 0 0 167 184 205 na 10.18% 11.41% 27.86 25.28 22.69 189 187 1.09%
NVS 0 0 0 0 501 522 561 na 4.19% 7.47% 18.14 17.41 16.20 570 521 9.39%
PFE 202 222 231 219 222 224 227 1.37% 0.90% 1.34% 13.41 13.29 13.12 232 220 5.36%
PRGO 0 293 401 499 561 620 759 12.42% 10.52% 22.42% 25.65 23.21 18.96 673 648 4.03%
RHHBY 0 274 279 325 384 408 444 18.15% 6.25% 8.82% 19.57 18.42 16.92 432 415 4.17%
STJ 234 301 328 239 376 399 431 57.32% 6.12% 8.02% 18.57 17.50 16.20 402 393 2.26%
SYK 295 333 372 407 423 481 529 3.93% 13.71% 9.98% 20.35 17.90 16.27 489 448 8.52%
TEVA 336 454 497 535 501 472 479 -6.36% -5.79% 1.48% 10.57 11.22 11.06 576 410 35.17%
TMO 0 0 416 494 542 690 786 9.72% 27.31% 13.91% 21.94 17.24 15.13 693 564 18.70%
ZMH 394 433 480 530 575 612 658 8.49% 6.43% 7.52% 18.36 17.25 16.05 630 583 7.68%
ZTS 0 0 0 108 142 154 174 31.48% 8.45% 12.99% 22.86 21.08 18.66 170 154 10.39%

BDC Average           7.63 6.85 10.52 20.17 18.82 17.03     8.97